BioLife Solutions Inc has reached a key milestone in its strategy to begin positioning the Company for future sales growth with the signing of a two-year manufacturing agreement with Herndon, VA-based Mediatech Inc, a leading manufacturer of cell culture media and reagents. Mediatech will be the primary manufacturer for BioLife's Hypothermosol family of preservation solutions.
BioLife President and CEO John G. Baust, said, "As we increase our focus on developing new business and revenue streams, an outsourced manufacturing solution makes perfect sense for our organization. With its state-of-the-art, sterile-fill production facility and decades of experience in 'solutions' manufacturing, Mediatech can provide us a reliable source of high quality product and help us control our costs, which is important at this stage of our development. By outsourcing our manufacturing we are also able to concentrate our resources where they can bring the greatest returns in the near term.
"Mediatech is highly regarded within the international cell-based biomedical community for its reliability and quality products and we are pleased to formalize our relationship," Baust added. "Mediatech has begun manufacturing Hypothermosol, with first shipments to occur this month."